Gartner® Report

Life Science CIO’s Strategy for Delivering Cell and Gene Therapy Capabilities

Life science organizations are looking to develop portfolios of personalized medicines and custom therapeutics, especially products delivered via new CGT platforms.

 

LSO CIOs can use this research to help successfully scale their organization’s CGT capability and avoid using the wrong approach.

 

In this Gartner report, you will discover how to:

  • Research CGT trends and model their impacts on your organization and architecture
  • Refine your CGT vision from discrete capabilities to a complete roadmap
  • Expose the gaps in your CGT plan by asking stakeholders the right questions
  • Deliver your CGT vision by aligning with ecosystem players
  • Determine which software and service providers can best support your roadmap

Download Gartner report now!

We’ll keep your email address safe.
We do not share your details with third parties.

Gartner is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved Gartner, Life Science CIO’s Strategy for Delivering Cell and Gene Therapy Capabilities, Michael Shanler, Jessica Hong, 4 October 2021.